Correlation Between NVIDIA CDR and Rakovina Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NVIDIA CDR and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NVIDIA CDR and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NVIDIA CDR and Rakovina Therapeutics, you can compare the effects of market volatilities on NVIDIA CDR and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NVIDIA CDR with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NVIDIA CDR and Rakovina Therapeutics.

Diversification Opportunities for NVIDIA CDR and Rakovina Therapeutics

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between NVIDIA and Rakovina is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding NVIDIA CDR and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and NVIDIA CDR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NVIDIA CDR are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of NVIDIA CDR i.e., NVIDIA CDR and Rakovina Therapeutics go up and down completely randomly.

Pair Corralation between NVIDIA CDR and Rakovina Therapeutics

Assuming the 90 days trading horizon NVIDIA CDR is expected to generate 0.46 times more return on investment than Rakovina Therapeutics. However, NVIDIA CDR is 2.17 times less risky than Rakovina Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Rakovina Therapeutics is currently generating about -0.24 per unit of risk. If you would invest  3,297  in NVIDIA CDR on August 27, 2024 and sell it today you would earn a total of  26.00  from holding NVIDIA CDR or generate 0.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NVIDIA CDR  vs.  Rakovina Therapeutics

 Performance 
       Timeline  
NVIDIA CDR 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in NVIDIA CDR are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, NVIDIA CDR may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Rakovina Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rakovina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

NVIDIA CDR and Rakovina Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NVIDIA CDR and Rakovina Therapeutics

The main advantage of trading using opposite NVIDIA CDR and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NVIDIA CDR position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.
The idea behind NVIDIA CDR and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Directory
Find actively traded commodities issued by global exchanges